121 related articles for article (PubMed ID: 38194619)
21. Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer.
Bestvina CM; Waters D; Morrison L; Emond B; Lafeuille MH; Hilts A; Lefebvre P; He A; Vanderpoel J
J Med Econ; 2024; 27(1):292-303. PubMed ID: 38391239
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experience.
Dall'Olio FG; Conci N; Rossi G; Fiorentino M; De Giglio A; Grilli G; Altimari A; Gruppioni E; Filippini DM; Di Federico A; Nuvola G; Ardizzoni A
Lung Cancer; 2020 Nov; 149():5-9. PubMed ID: 32932213
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Value and Cost-Effectiveness of Next-Generation Sequencing-Based Testing for Treatment of Patients with Advanced/Metastatic Non-Squamous Non-Small-Cell Lung Cancer in the United States.
Zou D; Ye W; Hess LM; Bhandari NR; Ale-Ali A; Foster J; Quon P; Harris M
J Mol Diagn; 2022 Aug; 24(8):901-914. PubMed ID: 35688357
[TBL] [Abstract][Full Text] [Related]
24. Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.
Palmero R; Taus A; Viteri S; Majem M; Carcereny E; Garde-Noguera J; Felip E; Nadal E; Malfettone A; Sampayo M; Riva F; Nagy RJ; Lanman RB; Faull I; Dix D; Karachaliou N; Rosell R
JCO Precis Oncol; 2021 Nov; 5():93-102. PubMed ID: 34994593
[TBL] [Abstract][Full Text] [Related]
25. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.
Eberly LA; Richterman A; Beckett AG; Wispelwey B; Marsh RH; Cleveland Manchanda EC; Chang CY; Glynn RJ; Brooks KC; Boxer R; Kakoza R; Goldsmith J; Loscalzo J; Morse M; Lewis EF; Abel S; Adams A; Anaya J; Andrews EH; Atkinson B; Avutu V; Bachorik A; Badri O; Bailey M; Baird K; Bakshi S; Balaban D; Barshop K; Baumrin E; Bayomy O; Beamesderfer J; Becker N; Berg DD; Berman AN; Blum SM; Boardman AP; Boden K; Bonacci RA; Brown S; Campbell K; Case S; Cetrone E; Charrow A; Chiang D; Clark D; Cohen AJ; Cooper A; Cordova T; Cuneo CN; de Feria AA; Deffenbacher K; DeFilippis EM; DeGregorio G; Deutsch AJ; Diephuis B; Divakaran S; Dorschner P; Downing N; Drescher C; D'Silva KM; Dunbar P; Duong D; Earp S; Eckhardt C; Elman SA; England R; Everett K; Fedotova N; Feingold-Link T; Ferreira M; Fisher H; Foo P; Foote M; Franco I; Gilliland T; Greb J; Greco K; Grewal S; Grin B; Growdon ME; Guercio B; Hahn CK; Hasselfeld B; Haydu EJ; Hermes Z; Hildick-Smith G; Holcomb Z; Holroyd K; Horton L; Huang G; Jablonski S; Jacobs D; Jain N; Japa S; Joseph R; Kalashnikova M; Kalwani N; Kang D; Karan A; Katz JT; Kellner D; Kidia K; Kim JH; Knowles SM; Kolbe L; Kore I; Koullias Y; Kuye I; Lang J; Lawlor M; Lechner MG; Lee K; Lee S; Lee Z; Limaye N; Lin-Beckford S; Lipsyc M; Little J; Loewenthal J; Logaraj R; Lopez DM; Loriaux D; Lu Y; Ma K; Marukian N; Matias W; Mayers JR; McConnell I; McLaughlin M; Meade C; Meador C; Mehta A; Messenger E; Michaelidis C; Mirsky J; Mitten E; Mueller A; Mullur J; Munir A; Murphy E; Nagami E; Natarajan A; Nsahlai M; Nze C; Okwara N; Olds P; Paez R; Pardo M; Patel S; Petersen A; Phelan L; Pimenta E; Pipilas D; Plovanich M; Pong D; Powers BW; Rao A; Ramirez Batlle H; Ramsis M; Reichardt A; Reiger S; Rengarajan M; Rico S; Rome BN; Rosales R; Rotenstein L; Roy A; Royston S; Rozansky H; Rudder M; Ryan CE; Salgado S; Sanchez P; Schulte J; Sekar A; Semenkovich N; Shannon E; Shaw N; Shorten AB; Shrauner W; Sinnenberg L; Smithy JW; Snyder G; Sreekrishnan A; Stabenau H; Stavrou E; Stergachis A; Stern R; Stone A; Tabrizi S; Tanyos S; Thomas C; Thun H; Torres-Lockhart K; Tran A; Treasure C; Tsai FD; Tsaur S; Tschirhart E; Tuwatananurak J; Venkateswaran RV; Vishnevetsky A; Wahl L; Wall A; Wallace F; Walsh E; Wang P; Ward HB; Warner LN; Weeks LD; Weiskopf K; Wengrod J; Williams JN; Winkler M; Wong JL; Worster D; Wright A; Wunsch C; Wynter JS; Yarbrough C; Yau WY; Yazdi D; Yeh J; Yialamas MA; Yozamp N; Zambrotta M; Zon R
Circ Heart Fail; 2019 Nov; 12(11):e006214. PubMed ID: 31658831
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea.
Ahn BC; Lee S; Lee J; Lee JB; Hong MH; Lim SM; Jain S; Olsen S; Cho BC
Cancer Treat Res Commun; 2023; 36():100715. PubMed ID: 37307681
[TBL] [Abstract][Full Text] [Related]
27. Patient Perceptions of their COVID-19 Inpatient Hospital Experience: a Survey Exploring Inequities in Healthcare Delivery.
Oppelt TF; Polsonetti B; Caron MF; Collins-Carriveau C; Fischer N; Gofman L; Ghazipura M
J Racial Ethn Health Disparities; 2023 Dec; 10(6):2775-2782. PubMed ID: 36417149
[TBL] [Abstract][Full Text] [Related]
28. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
29. Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer.
Yu TM; Morrison C; Gold EJ; Tradonsky A; Arnold RJG
Value Health; 2018 Nov; 21(11):1278-1285. PubMed ID: 30442274
[TBL] [Abstract][Full Text] [Related]
30. Racial and ethnic differences in the relationship between financial worry and white matter hyperintensities in Latinx, non-Latinx Black, and non-Latinx White older adults.
Morris EP; Turney IC; Palms JD; Zaheed AB; Sol K; Amarante E; Beato J; Chesebro AG; Morales CD; Manly JJ; Brickman AM; Zahodne LB
Neurobiol Aging; 2023 Sep; 129():149-156. PubMed ID: 37331245
[TBL] [Abstract][Full Text] [Related]
31. Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Stricker T; Jain N; Ma E; Yu E; Wang R; Schuldt R; Price R; Szado T; Sussell J; Ogale S; Lin V; Arrowsmith E; Slater D; Vaena D; Staszewski H; Fang B; Seneviratne L; Daniel D
Oncologist; 2024 Jun; 29(6):534-542. PubMed ID: 38417095
[TBL] [Abstract][Full Text] [Related]
32. Race, ethnicity, and emergency department post-overdose care.
Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
[TBL] [Abstract][Full Text] [Related]
33. Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer.
Vanderpoel J; Stevens AL; Emond B; Lafeuille MH; Hilts A; Lefebvre P; Morrison L
J Med Econ; 2022; 25(1):457-468. PubMed ID: 35289703
[TBL] [Abstract][Full Text] [Related]
34. Comparison of All-Cause Mortality Rates and Inequities Between Black and White Populations Across the 30 Most Populous US Cities.
Benjamins MR; Silva A; Saiyed NS; De Maio FG
JAMA Netw Open; 2021 Jan; 4(1):e2032086. PubMed ID: 33471116
[TBL] [Abstract][Full Text] [Related]
35. Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital.
Burns L; Jani C; Radwan A; Omari OA; Patel M; Oxnard GR; Tapan U
Clin Lung Cancer; 2023 Mar; 24(2):e69-e77. PubMed ID: 36464575
[TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice.
H Araujo L; Ferreira CG; Baldotto CS; Mathias C; Castro G; Coudry R
Future Oncol; 2021 Jan; 17(2):205-213. PubMed ID: 33052747
[TBL] [Abstract][Full Text] [Related]
37. Trends in real-world biomarker testing and overall survival in US patients with advanced non-small-cell lung cancer.
Wu N; Ge W; Quek RG; Gleeson M; Pouliot JF; Dietz H; Jalbert JJ; Harnett J; Antonia SJ
Future Oncol; 2022 Dec; 18(39):4385-4397. PubMed ID: 36656547
[TBL] [Abstract][Full Text] [Related]
38. Geographic and Temporal Patterns in Covid-19 Mortality by Race and Ethnicity in the United States from March 2020 to February 2022.
Lundberg DJ; Cho A; Raquib R; Nsoesie EO; Wrigley-Field E; Stokes AC
medRxiv; 2022 Jul; ():. PubMed ID: 35898347
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of next-generation sequencing test for patients with advanced NSCLC in clinical practice.
Ariyasu R; Uchibori K; Ninomiya H; Ogusu S; Tsugitomi R; Manabe R; Sakamaoto H; Tozuka T; Yoshida H; Amino Y; Kitazono S; Yanagitani N; Takeuchi K; Nishio M
Thorac Cancer; 2021 Feb; 12(4):504-511. PubMed ID: 33350072
[TBL] [Abstract][Full Text] [Related]
40. Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status.
Holt HK; Peterson CE; MacLaughlan David S; Abdelaziz A; Sawaya GF; Guadamuz JS; Calip GS
JAMA Netw Open; 2023 Mar; 6(3):e232985. PubMed ID: 36897588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
